Clinical Guides
Dry Eye Disease
A clinically focused guide to recognizing, classifying and managing dry eye disease in Indian clinical practice, with explicit diagnostic limits, ocular-surface safety checks and referral thresholds.
MedNext Academy | 13 min read
Dry Eye Disease
A clinically focused guide to recognizing, classifying and managing dry eye disease in Indian clinical practice, with explicit diagnostic limits, ocular-surface safety checks and referral thresholds.
Summary
Dry eye disease is a multifactorial, symptomatic disorder in which homeostasis of the tear film or ocular surface is lost. Tear-film instability, hyperosmolarity, surface inflammation or damage, and altered corneal sensation may contribute in different proportions. The modern concept is broader than simple tear deficiency: lipid, aqueous and mucin-related deficits can coexist with incomplete blinking, eyelid disease, exposure, contact-lens effects, iatrogenic injury or neural dysfunction. Symptoms include dryness, burning, grittiness, fluctuating blur, photophobia and reflex watering. The apparent paradox of watering occurs because irritation can trigger lacrimation even when the stable basal tear film is inadequate.
Diagnosis requires compatible symptoms plus objective evidence of disrupted ocular-surface homeostasis after excluding important mimics. Symptom severity and visible signs may diverge; severe pain with few surface findings raises the possibility of neuropathic mechanisms, while reduced corneal sensation can produce significant epithelial disease with muted symptoms. Management is individualized to the driver rather than reduced to indefinite lubricant use. It may include environmental and blink measures, treatment of lid-margin disease, appropriate tear supplementation, medicine review, anti-inflammatory therapy or tear conservation under eye-care supervision. Sudden visual loss, substantial photophobia, corneal opacity, contact-lens-associated pain, chemical injury or suspected infection is not routine dry eye and requires urgent assessment. This educational draft does not authorize patient-specific treatment and remains quarantined following MedNext Clinical Team review.
How Common Is It?
Dry eye is encountered frequently in eye care, primary care and clinics that manage diabetes, autoimmune disease, menopause, contact lenses or prolonged screen exposure. Reported prevalence varies widely because studies use different questionnaires, tests, thresholds, age ranges and sampling methods. TFOS DEWS III emphasizes a standardized diagnostic approach partly because inconsistent definitions have made populations difficult to compare. A symptom survey alone, a single low tear measurement or incidental meibomian-gland change does not establish the same clinical entity in every study.
Burden rises with age and is often greater in women, although sex, hormonal status, systemic disease, medicines and environmental exposure interact. Urban air pollution, low humidity, air conditioning, sustained visual tasks and reduced blink completeness can worsen symptoms. In India, outdoor heat, dust, occupational exposure, screen-based study or work, unregulated topical preparations and variable access to slit-lamp examination may shape presentation. These are plausible clinical influences, not a basis for inventing a national prevalence estimate.
Population burden also includes impaired reading, driving, work, sleep and contact-lens tolerance, plus repeated expenditure on over-the-counter drops. Symptoms may fluctuate, so a normal examination on one visit does not invalidate the history. Conversely, labeling every irritable eye as dry eye risks missing allergy, infection, uveitis, exposure keratopathy or medicine toxicity. Local service data and consistently applied criteria are preferable to quoting a single headline percentage as if it applied across India.
Risk Factors
Risk assessment should cover tear production, evaporation, eyelid function, ocular-surface integrity, neural input, systemic disease and treatment exposures. Increasing age, female sex, menopause, Sjögren disease and other autoimmune disorders, graft-versus-host disease, diabetes, thyroid disease, Parkinson disease and connective-tissue disorders may contribute. Ask about dry mouth, dental caries, salivary swelling, joint symptoms, rashes, neuropathy and constitutional features when systemic disease is plausible; ocular symptoms alone do not diagnose Sjögren disease.
Ocular risks include meibomian-gland dysfunction, blepharitis, rosacea, incomplete lid closure, reduced or incomplete blinking, ectropion, entropion, facial-nerve weakness, conjunctival scarring and reduced corneal sensation. Contact-lens wear, refractive surgery, cataract surgery and chronic exposure to preserved topical medicines can disturb the ocular surface. Systemic medicines associated with dryness include drugs with anticholinergic effects, some antihistamines, antidepressants, isotretinoin, diuretics and other agents; association does not justify abrupt discontinuation. Record every eye drop, cosmetic, traditional preparation and recent procedure.
Environmental contributors include low humidity, airflow from fans or air conditioners, smoke, dust, air pollution and sustained near work that reduces blink frequency or completeness. Vitamin A deficiency is an important but distinct nutritional risk in appropriate clinical settings; advanced ocular signs require specialist care. Corneal anaesthesia, chemical injury and cicatrizing disease are high-risk contexts because symptoms can underestimate tissue damage. Risk factors help select tests and management targets, but no single exposure confirms the diagnosis.
Diagnosis
History
Clarify dryness, burning, grittiness, soreness, watering, photophobia and visual fluctuation, including laterality, timing, triggers and functional impact. Ask whether blur clears after blinking, whether symptoms worsen late in the day or with screens, and whether contact lenses are involved. Elicit discharge, itch, marked pain, trauma, chemical exposure, surgery, topical medicines, dry mouth and autoimmune features. Sudden onset, pronounced unilateral symptoms, severe photophobia or reduced vision demands a broader urgent differential. A validated symptom instrument can standardize symptom capture, but it does not replace clinical assessment.
Examination
Record monocular visual acuity before drops and inspect face, blink completeness, lid closure, lashes, lid margins and meibomian-gland orifices. Slit-lamp assessment examines the tear meniscus, debris, conjunctiva, cornea and staining pattern. Corneal sensation should be considered before instilling anaesthetic, especially when signs and symptoms disagree. Measure tear-film breakup with a standardized method and assess fluorescein or lissamine-green staining when trained and equipped. Examine for follicles, papillae, focal infiltrate, epithelial defect, anterior-chamber activity, exposure and lid malposition.
Investigations
TFOS DEWS III recommends a symptom screen followed by an objective homeostasis marker; its standardized pathway uses OSDI-6 and defined thresholds for non-invasive breakup time, osmolarity or ocular-surface staining. Equipment and licensing may limit use, and thresholds must follow the cited method rather than being transferred between devices. Tests that subclassify drivers include meibomian expressibility and quality, tear volume or flow, blink and lid-closure assessment, and selected imaging. Schirmer testing can support aqueous-deficiency assessment but varies with technique and reflex tearing. Autoimmune or nutritional investigations are targeted to history and examination rather than ordered as a universal panel.
Differential Diagnosis
Allergic conjunctivitis usually features itch, chemosis or papillary change and may coexist with dry eye. Infectious conjunctivitis is suggested by contagious exposure, discharge and characteristic conjunctival findings; contact-lens wear raises concern for microbial keratitis when pain, photophobia, reduced vision or a corneal infiltrate is present. Blepharitis and meibomian-gland dysfunction are common drivers or comorbidities rather than interchangeable labels. Recurrent erosion causes episodic sharp pain, often on waking, while corneal foreign body or abrasion follows exposure or trauma.
Uveitis, scleritis, episcleritis and acute angle closure must be considered in a painful red eye. Uveitis often causes photophobia and anterior-chamber inflammation; scleritis produces deep tenderness or pain; angle closure may cause corneal haze, headache, nausea and a mid-dilated pupil. Exposure keratopathy results from incomplete closure, proptosis, facial palsy or reduced blink. Medicamentosa from preserved glaucoma drops, vasoconstrictors, topical anaesthetics or unregulated products can perpetuate surface damage. Superior limbic keratoconjunctivitis, conjunctivochalasis, pterygium and cicatrizing disorders can produce overlapping symptoms.
Neuropathic ocular pain is suspected when burning or photoallodynia is disproportionate to surface findings, persists despite restoration of the surface, or accompanies other pain syndromes; it remains a diagnosis requiring careful ocular and neurological consideration. Reduced corneal sensation creates the opposite mismatch and may signal neurotrophic disease. Refractive error, accommodative strain and migraine can cause visual discomfort without tear-film disease. The differential is resolved by history, visual acuity, slit-lamp findings, sensation and appropriately sequenced tests, not by a therapeutic trial alone.
Management
Explain that dry eye is heterogeneous and often chronic, with treatment directed at identified contributors and reassessed for objective and functional response. Begin by removing avoidable aggravators: improve blink completeness during sustained near work, take task breaks, redirect fans, consider humidification, use outdoor eye protection, stop smoke exposure and optimize contact-lens habits. Review topical and systemic medicines with the prescriber; do not instruct abrupt cessation of essential therapy. Treat lid malposition, exposure, allergy or meibomian-gland dysfunction when present rather than escalating lubricants blindly.
Ocular lubricants replenish the tear film but differ in viscosity, lipid content, osmolarity and preservatives. Frequent users or people with epithelial disease may benefit from preservative-free formulations, subject to availability and handling. Gels or ointments can last longer but blur vision and may be used at night in selected cases. Warm compresses and lid care are relevant when lid-margin or meibomian disease is identified, with safe temperature and hygiene instruction. Punctal occlusion conserves tears but should follow evaluation of surface inflammation and drainage; plugs are not a universal first step.
Persistent inflammatory disease may require ophthalmologist-directed anti-inflammatory treatment, autologous serum or platelet-derived products, moisture-chamber devices, therapeutic lenses or procedures matched to the driver. TFOS DEWS III reviews these options but does not convert them into one sequence for every patient. Address systemic Sjögren disease, vitamin A deficiency or exposure with the relevant team. Agree measurable goals such as reading tolerance, reduced staining or stable vision, and verify technique, adherence, cost and adverse effects before declaring treatment failure.
Prescribing Information
Prescribing starts with product identity, laterality, frequency, duration and review date. Artificial tears are not pharmacologically identical: aqueous, lipid-containing, gel and ointment products have different roles, and multidose bottles may contain preservatives. Benzalkonium chloride and other preservatives can aggravate an already compromised surface with frequent exposure. Single-dose preservative-free units reduce preservative load but require clean handling and may be costly. Patients should not touch the nozzle to lashes or eye, share bottles, or continue a contaminated product. Ointment can temporarily blur vision, so driving immediately after use is unsafe.
Topical corticosteroids can reduce ocular-surface inflammation but may raise intraocular pressure, accelerate cataract, delay epithelial healing or worsen infection. They require a defined indication, limited course and appropriate monitoring; a painful contact-lens wearer or undiagnosed corneal epithelial lesion should not receive empiric steroid. Topical ciclosporin or other immunomodulatory medicines have formulation-specific indications, onset, tolerability and licensing. Availability and approved labeling differ in India, and the cited international consensus is not a substitute for the current Indian product information or a local ophthalmologist's prescription.
Topical antibiotics do not treat uncomplicated dry eye. Oral tetracycline-class drugs may be considered for selected meibomian or rosacea-associated disease, but contraindications, pregnancy, photosensitivity, gastrointestinal effects, antimicrobial stewardship and local guidance matter. Never use topical anaesthetic as take-home analgesia because repeated use can cause severe corneal toxicity. Medication changes should be documented and reviewed against symptoms, acuity, staining and pressure where relevant.
When to Refer
Refer routinely to optometry or ophthalmology when symptoms persist despite a safe first-line trial, diagnosis is uncertain, visual function is affected, signs are moderate or severe, or contact-lens tolerance remains poor. Specialist assessment is appropriate for recurrent epithelial breakdown, marked staining, filamentary keratitis, reduced corneal sensation, suspected aqueous deficiency, significant meibomian-gland dysfunction, lid malposition, exposure, ocular-surface scarring or pain disproportionate to signs. Refer for systemic evaluation when history suggests Sjögren disease, connective-tissue disease, graft-versus-host disease, thyroid disease or nutritional deficiency; the receiving pathway may begin with ophthalmology, medicine, rheumatology or paediatrics depending on presentation.
Expedite referral after ocular surgery when the surface is unstable enough to affect keratometry, healing or visual rehabilitation. A patient using multiple preserved glaucoma drops may need coordinated review rather than unilateral cessation. Children, people with only one functional eye and those unable to report deterioration need a lower threshold.
Same-day ophthalmic assessment is required for significant photophobia, reduced acuity, focal corneal opacity or infiltrate, epithelial defect with contact-lens use, suspected infection, anterior-chamber inflammation, chemical injury, new corneal anaesthesia with epithelial disease, or rapidly progressive unilateral symptoms. Indian referral routes vary; confirm where slit-lamp examination and emergency corneal care are actually available instead of giving an abstract instruction to see a specialist.
Red Flags
Pain severe enough to wake the patient, rapidly falling vision, marked photophobia, a focal white corneal lesion, dense haze, hypopyon, irregular pupil or vomiting with ocular pain is not explained by uncomplicated dry eye. A contact-lens wearer with pain or reduced vision has microbial keratitis until appropriately examined. Remove the lens, retain it and its case if local microbiology requests them, avoid patching or steroid, and arrange urgent ophthalmic care. A chemical splash requires immediate copious irrigation before a complete history; referral must not delay irrigation.
Exposure with inability to close the eye, new facial weakness, proptosis or reduced consciousness threatens the cornea. Reduced sensation can hide worsening epithelial loss, particularly after herpes infection, neurosurgery, diabetes or repeated topical anaesthetic exposure. Conjunctival scarring, symblepharon, lid-margin keratinization or progressive shortening of the fornix suggests cicatrizing disease and needs specialist assessment. Purulent discharge, preseptal swelling with systemic illness, vesicular rash near the eye or painful limitation of eye movement points away from routine dryness.
Systemic red flags include dry eye with substantial dry mouth, parotid swelling, inflammatory joint symptoms, vasculitic features, graft-versus-host disease or severe malnutrition. These require coordinated evaluation but are not diagnosed from symptoms alone. Finally, repeated purchase of unlabelled steroid, anaesthetic, vasoconstrictor or traditional drops is itself a safety signal. Identify the bottle, stop only when clinically appropriate, assess the cornea and pressure, and document advice.
Indian Clinical Context
The Indian context combines a large, diverse patient population with uneven access to optometry, slit-lamp examination, preservative-free products, tear-film devices and corneal subspecialists. The Ministry of Health and Family Welfare primary-eye-care framework supports assessment of common eye complaints, visual acuity measurement, early management within competence and referral through linked facilities. It does not provide a dry-eye drug protocol or guarantee that every Health and Wellness Centre has advanced tear diagnostics. This guide therefore uses TFOS consensus for clinical principles while explicitly avoiding claims that its devices, thresholds or medicines are uniformly available in India.
Ask about occupations involving dust, wind, heat, smoke, air conditioning or prolonged display use. Cost matters: repeated purchase of branded drops without a diagnosis can consume household income while preservative toxicity or lid disease remains unaddressed. Explain safe bottle handling in the patient's preferred language and verify that the chosen formulation can be obtained consistently. Unregulated combination drops may contain corticosteroid or vasoconstrictor; inspect the label rather than relying on colour or brand recollection. Contact-lens counselling should include water avoidance, case hygiene and prompt cessation with pain.
Referral plans must be concrete. District hospitals, medical colleges, charitable eye hospitals and private clinics differ in emergency cover, rheumatology links and availability of serum tears or therapeutic lenses. Document the destination, urgency, transport constraints and interim corneal protection. National programme material provides the service framework; local protocols, current Indian labeling and clinician judgement govern prescribing. No foreign consensus statement should be presented as an Indian statutory standard.
NMC Competency Mapping
The NMC Competency Based Medical Education Curriculum 2024 maps dry eye directly to ophthalmology competency OP4.5. The learner is expected to describe the tear film, enumerate causes of dry eyes, and describe clinical features and management. This guide supports that knowledge-and-application outcome by connecting tear-film layers and ocular-surface homeostasis to aqueous, lipid, mucin, eyelid, exposure and neural contributors. It also reinforces OP3.1, which covers supervised history taking in a patient with red eye and enumeration of red-eye causes, because dry-eye symptoms must be distinguished from urgent corneal, uveal and pressure-related disease.
A competent undergraduate should obtain a symptom and exposure history, measure visual acuity, inspect blink and lid closure, recognize lid-margin disease, describe tear breakup and staining, and explain why symptom-sign discordance occurs. Students should know the purpose and limitations of Schirmer testing, breakup-time methods, osmolarity and surface dyes without claiming independent proficiency after reading. They should formulate a driver-based initial plan and state clear referral triggers.
The curriculum mapping is educational, not a credential. Corneal sensation testing, contact-lens-related red-eye assessment, punctal procedures and prescription of corticosteroid or immunomodulatory therapy require appropriate supervision and scope. Examination answers should use current disease concepts while respecting the exact competence: describe, enumerate and manage conceptually. Local department teaching and assessed clinical skills determine what a learner may perform.
Key Exam Pearls for NEET PG
The tear film is an integrated mucoaqueous and lipid system rather than three completely separate sheets. The lacrimal functional unit includes the ocular surface, lacrimal glands, meibomian glands, lids and sensory-motor innervation. Aqueous deficiency and evaporative disease often overlap. Meibomian-gland dysfunction is a major cause of evaporative instability. Reflex watering does not exclude dry eye, and fluctuating vision that improves after blinking suggests tear-film disturbance.
Diagnosis needs symptoms and signs after excluding mimics. Measure acuity first. Tear-film breakup evaluates stability; ocular-surface dyes demonstrate epithelial or conjunctival damage; Schirmer testing estimates aqueous production but is variable and technique-dependent. Reduced corneal sensation can produce severe damage with little discomfort, whereas neuropathic pain can produce severe symptoms with minimal staining. Filamentary keratitis, exposure and contact-lens-associated infiltrate deserve escalation.
First-line management removes aggravators, improves blink and environment, treats lid disease and uses an appropriate lubricant. Frequent drops favor preservative-free choices when feasible. Topical steroid is not a casual treatment: monitor pressure and exclude infection. Punctal occlusion conserves tears but does not correct every inflammatory surface. Severe aqueous deficiency may need systemic evaluation and specialist therapies. For an exam vignette, pain, photophobia, focal opacity or reduced vision shifts the answer from routine lubricant advice to urgent slit-lamp assessment, particularly in a contact-lens wearer. OP4.5 is the direct NMC anchor for tear film, causes, features and management of dry eye.
Frequently Asked Questions
Can dry eye cause watering instead of a feeling of dryness?
Yes. An unstable or damaged ocular surface can trigger reflex tearing, so watering does not exclude dry eye. The tears may be poorly retained or have an abnormal lipid component. Persistent unilateral watering also requires assessment for lid-position or tear-drainage disease rather than automatic treatment with lubricant.
Is prolonged screen use the sole cause of dry eye disease?
No. Sustained visual tasks can reduce blink frequency and completeness, worsening evaporation, but dry eye is multifactorial. Lid-margin disease, medicines, contact lenses, autoimmune disease, surgery, exposure and neural dysfunction may contribute. A clinician should assess the pattern rather than attributing every symptom to screen time.
When should preservative-free artificial tears be considered?
They are often considered when drops are needed frequently, the ocular surface is damaged, multiple preserved medicines are already used, or preservative sensitivity is suspected. Product choice still depends on the identified tear-film deficit, handling ability, availability and cost; preservative-free packaging does not remove contamination risk.
Which dry-eye symptoms need urgent eye assessment rather than self-treatment?
Reduced vision, severe pain, marked photophobia, a focal white corneal spot, significant trauma, chemical exposure, inability to close the eye or painful redness in a contact-lens wearer requires urgent assessment. These findings can indicate infection, exposure, inflammation or injury and should not be masked with steroid or anaesthetic drops.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic